VTGN NASDAQ
VistaGen Therapeutics, Inc.
1W: +2.9%
1M: +14.2%
3M: +14.3%
YTD: -58.6%
1Y: -92.1%
3Y: -94.7%
5Y: -99.7%
$0.28
-0.00 (-0.57%)
Weekly Expected Move ±27.4%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-12-21
Earliest Filing
2023-09-08
Latest Filing
partner: 2
acquirer: 2
target: 1
Counterparties (Filed by VTGN)
5 relationshipsCompanies named in VTGN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Vistagen Therapeutics, Inc. | VSTM | partner | Entered into an exclusive negotiation agreement with Fuji Pharma for a potential commercialization deal in Japan. | 2023-09-08 | View |
| Fuji Pharma Co., Ltd. | — | partner | Entered into an exclusive negotiation agreement with Vistagen Therapeutics, Inc. for a potential commercialization deal | 2023-09-08 | View |
| VISTAGEN THERAPEUTICS, INC. | VTGN | acquirer | Parent company acquiring Pherin Pharmaceuticals in a merger transaction. | 2022-12-21 | View |
| VTGN MERGER SUB, INC. | — | acquirer | Special purpose acquisition vehicle used by Vistagen Therapeutics to merge with Pherin Pharmaceuticals. | 2022-12-21 | View |
| PHERIN PHARMACEUTICALS, INC. | — | target | Target company being merged into Vistagen Therapeutics. | 2022-12-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-25 | Regulation FD; Exhibits | View | |
| 2026-09-24 | Other Events; Exhibits | View | |
| 2026-09-22 | Other Events; Exhibits | View | |
| 2026-09-11 | Shareholder Vote; Exhibits | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-06 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-05 | Delisting Notice | View | |
| 2026-07-31 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-30 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-17 | Officer/Director Change | View | |
| 2026-06-15 | Earnings Release; Exhibits | View | |
| 2026-06-09 | Other Events; Exhibits | View | |
| 2026-05-19 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-12 | Other Events; Exhibits | View | |
| 2026-05-08 | Other Events; Exhibits | View | |
| 2026-04-28 | Other Events; Exhibits | View | |
| 2026-04-13 | Officer/Director Change | View | |
| 2026-04-02 | Delisting Notice | View | |
| 2026-03-16 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-11 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR